Australia markets open in 3 hours 36 minutes

Rhythm Pharmaceuticals, Inc. (RYTM)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
39.76+0.94 (+2.42%)
At close: 04:00PM EDT
39.76 0.00 (0.00%)
After hours: 04:20PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts9999
Avg. Estimate-2.16-0.68-4.14-2.07
Low estimate-2.41-0.8-4.95-3.84
High estimate-0.61-0.59-2.44-0.79
Year ago EPS-0.92-0.82-3.2-4.14
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts8899
Avg. Estimate26.9M31.2M131.61M206.2M
Low estimate25.8M29.6M123.39M164.72M
High estimate28M33.9M137.78M298.46M
Year ago sales11.47M19.22M77.43M131.61M
Sales growth (year/est)134.50%62.30%70.00%56.70%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-0.9-0.79-0.74-0.7
Actual EPS-0.92-0.82-0.76-0.7
Difference-0.02-0.03-0.020
Surprise %-2.20%-3.80%-2.70%0.00%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-2.16-0.68-4.14-2.07
7 days ago-2.16-0.68-4.17-2.06
30 days ago-2.15-0.66-4.11-2.01
60 days ago-2.12-0.65-4.09-2.18
90 days ago-0.7-0.64-2.47-1.38
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/A1N/A
Up last 30 daysN/AN/A1N/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/A11
Growth estimatesRYTMIndustrySector(s)S&P 500
Current qtr.-134.80%N/AN/AN/A
Next qtr.17.10%N/AN/AN/A
Current year-29.40%N/AN/AN/A
Next year50.00%N/AN/AN/A
Next 5 years (per annum)-9.00%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A